GMAB vs. SANM
GMAB (Genmab A/S) and SANM (Sanmina Corporation) are both stocks. GMAB operates in Biotechnology (Healthcare), while SANM operates in Electronic Components (Technology). Over the past 10 years, GMAB returned 4.44%/yr vs 25.40%/yr for SANM. At a 0.13 correlation, their price movements are largely independent.
Performance
GMAB vs. SANM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GMAB achieves a -16.85% return, which is significantly lower than SANM's 68.89% return. Over the past 10 years, GMAB has underperformed SANM with an annualized return of 4.44%, while SANM has yielded a comparatively higher 25.40% annualized return.
GMAB
- 1D
- 1.35%
- 1M
- -4.69%
- YTD
- -16.85%
- 6M
- -22.53%
- 1Y
- 21.03%
- 3Y*
- -12.62%
- 5Y*
- -9.34%
- 10Y*
- 4.44%
SANM
- 1D
- 4.95%
- 1M
- 2.84%
- YTD
- 68.89%
- 6M
- 65.77%
- 1Y
- 182.08%
- 3Y*
- 64.62%
- 5Y*
- 45.86%
- 10Y*
- 25.40%
GMAB vs. SANM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GMAB Genmab A/S | -16.85% | 47.58% | -34.45% | -24.87% | 7.13% | -2.71% | 82.09% | 35.54% | -0.61% | -0.04% |
SANM Sanmina Corporation | 68.89% | 98.32% | 47.30% | -10.33% | 38.18% | 30.01% | -6.86% | 42.31% | -27.09% | -9.96% |
Correlation
The correlation between GMAB and SANM is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2009 | 0.13 |
Fundamentals
GMAB:
$16.35B
SANM:
$14.02B
GMAB:
$4.10
SANM:
$4.72
GMAB:
6.25
SANM:
53.65
GMAB:
0.41
SANM:
10.46
GMAB:
1.85
SANM:
1.23
GMAB:
2.88
SANM:
1.99
GMAB:
$8.84B
SANM:
$11.34B
GMAB:
$8.27B
SANM:
$968.36M
GMAB:
$3.81B
SANM:
$365.81M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GMAB vs. SANM — Risk / Return Rank
GMAB
SANM
GMAB vs. SANM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Genmab A/S (GMAB) and Sanmina Corporation (SANM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMAB | SANM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.07 | ||
| Sortino ratioReturn per unit of downside risk | -1.97 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.43 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | 0.65 | 5.60 | -4.96 |
| Martin ratioReturn relative to average drawdown | 1.39 | 13.88 | -12.49 |
Loading charts...
Drawdowns
GMAB vs. SANM - Drawdown Comparison
The maximum GMAB drawdown since its inception was -84.20%, smaller than the maximum SANM drawdown of -99.66%. Use the drawdown chart below to compare losses from any high point for GMAB and SANM.
Loading charts...
Drawdown Indicators
| GMAB | SANM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.20% | -99.66% | +15.46% |
Max Drawdown (1Y)Largest decline over 1 year | -32.51% | -32.69% | +0.18% |
Max Drawdown (3Y)Largest decline over 3 years | -57.44% | -32.69% | -24.75% |
Max Drawdown (5Y)Largest decline over 5 years | -63.10% | -33.92% | -29.18% |
Max Drawdown (10Y)Largest decline over 10 years | -63.10% | -55.85% | -7.25% |
Current DrawdownCurrent decline from peak | -47.43% | -28.40% | -19.03% |
Average DrawdownAverage peak-to-trough decline | -31.11% | -71.40% | +40.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.20% | 13.18% | +2.02% |
Volatility
GMAB vs. SANM - Volatility Comparison
The current volatility for Genmab A/S (GMAB) is 10.70%, while Sanmina Corporation (SANM) has a volatility of 18.87%. This indicates that GMAB experiences smaller price fluctuations and is considered to be less risky than SANM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GMAB | SANM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.70% | 18.87% | -8.17% |
Volatility (6M)Calculated over the trailing 6-month period | 25.38% | 48.93% | -23.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.31% | 68.46% | -34.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.50% | 44.58% | -11.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.10% | 42.13% | -7.03% |
Dividends
GMAB vs. SANM - Dividend Comparison
Neither GMAB nor SANM has paid dividends to shareholders.
Financials
GMAB vs. SANM - Financials Comparison
This section allows you to compare key financial metrics between Genmab A/S and Sanmina Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GMAB vs. SANM - Profitability Comparison
GMAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a gross profit of 834.08M and revenue of 899.32M. Therefore, the gross margin over that period was 92.8%.
SANM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported a gross profit of 354.98M and revenue of 4.01B. Therefore, the gross margin over that period was 8.9%.
GMAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported an operating income of 225.83M and revenue of 899.32M, resulting in an operating margin of 25.1%.
SANM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported an operating income of 157.01M and revenue of 4.01B, resulting in an operating margin of 3.9%.
GMAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a net income of 53.20M and revenue of 899.32M, resulting in a net margin of 5.9%.
SANM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported a net income of 93.65M and revenue of 4.01B, resulting in a net margin of 2.3%.
Frequently Asked Questions
GMAB and SANM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SANM has higher volatility (18.87%) compared to GMAB (10.70%). In terms of maximum drawdown, GMAB dropped -84.20% vs SANM's -99.66%.
SANM currently has the higher Sharpe Ratio (2.68 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GMAB and SANM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer